Pharmakon Pharmaceuticals, Inc.

FDA Regulatory Profile

Pharmakon Pharmaceuticals, Inc. has 116 FDA recalls (5 Class I), 3 inspections, 0 510(k) clearances and 1 compliance action on record.

Latest recall
D-1312-2016 · Class II · Apr 20, 2016
Latest inspection
Mar 16, 2016 · OAI

Reviewing Pharmakon Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Pharmakon Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls116 (5 Class I)Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections3Nov 11, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Recent Recalls

NumberClassProductDate
D-1312-2016Class IIHydromorphone HCI 1 mg/mL in 0.9% Sodium Chloride, 50 mL lntravia bag IV USE ONLY, Rx Only…Apr 20, 2016
D-1313-2016Class IIAtropine Sulfate 0.4mg/mL 2.5 mL fill in a 3 mL syringe, Rx Only, Compounded by PHARMAKON…Apr 20, 2016
D-1338-2016Class IIMidazolam HCI 1mg/mL in 0.9% Sodium Chloride ,2 mL fill in a 3 mL syringe; Compounded by PHARMAKON…Apr 20, 2016
D-1341-2016Class IIMidazolam HCl 1mg/mL in 0.9% Sodium Chloride, 50 mL Intravia bag, Rx Only, Compounded by PHARMAKON…Apr 20, 2016
D-1343-2016Class IIBupivacaine HCI 0.25% in 0.9% Sodium Chloride, 500 mL Intravia bag, Rx Only, Compounded by…Apr 20, 2016
D-1258-2016Class IIFentanyl Citrate 2 mcg/mL/Ropivacaine HCI 0.2% injection in 0.9% Sodium Chloride, 100 mL bag, Rx…Apr 20, 2016
D-1325-2016Class IIHYDROmorphone HCI 1mg/mL in 0.9% Sodium Chloride 30 mL fill in a 35 mL Monoject Plungerless Syringe…Apr 20, 2016
D-1266-2016Class IIEpinephrine (PF) 10mcg/mL in 0.9% Sodium Chloride, 5ml syringe, Rx Only, Compounded by PHARMAKON…Apr 20, 2016
D-1326-2016Class IIHYDROmorphone HCI 0.2 mg/mL in 0.9% Sodium Chloride 50 mL fill in a 60 mL Monoject Syringe, Rx Only…Apr 20, 2016
D-1275-2016Class IIPromethazine 12.5mg added to 0.9% Sodium Chloride 50 mL fill in a 100 mL B/Braun PAB bag, Rx Only…Apr 20, 2016
D-1256-2016Class IIPhenylephrine 40 mcg/mL injection in 0.9% Sodium Chloride 10 mL syringe, Rx Only, Compounded by…Apr 20, 2016
D-1286-2016Class IIFentanyl Citrate 25 mcg/mL in 0.9% Sodium Chloride 25 mL in 30 mL syringe, Rx Only, Compounded by…Apr 20, 2016
D-1298-2016Class IIOxytocin 30 Units added to Lactated Ringers in a 500 mL lntravia bag, Rx Only, Compounded by…Apr 20, 2016
D-1281-2016Class IIMorphine Sulfate (PF) 0.5mg/mL in 0.9% Sodium Chloride 1mL fill in a 3 mL syringe, Rx Only…Apr 20, 2016
D-1329-2016Class IIKetamine 2 mg/mL in 0.9% Sodium Chloride 30 mL fill in a 35 mL Monoject Plungerless syringe, Rx…Apr 20, 2016
D-1287-2016Class IIKetamine 50mg/mL in 0.9% Sodium Chloride 1mL fill in 3 mL syringe, Rx Only, Compounded by PHARMAKON…Apr 20, 2016
D-1304-2016Class IIHYDROmorphone HCI 0.4mg/ml in 0.9% Sodium Chloride, 30 mL PCA Vial, Rx Only, Compounded by PHARMAKON…Apr 20, 2016
D-1320-2016Class IIFentanyl Citrate 2mcg/mL & Ropivacaine HCI 0.2% in 0.9% Sodium Chloride, 100 mL bag, Compounded by…Apr 20, 2016
D-1283-2016Class IIMorphine Sulfate 1mg/mL in 0.9% Sodium Chloride 50 mL fill in a 50 mL Cadd Cassette (grey), Rx Only…Apr 20, 2016
D-1310-2016Class IIFentanyl Citrate 5 mcg/mL & Bupivacaine 0.06% in 0.9% Sodium Chloride, 60 mL BD Syringe, Rx Only…Apr 20, 2016

Recent FDA Inspections

DateSiteProductClassificationFEI
Mar 16, 2016Noblesville, INDrugsOfficial Action Indicated (OAI)3008213711
Apr 8, 2014Noblesville, INDrugsOfficial Action Indicated (OAI)3008213711
Mar 13, 2014Noblesville, INDrugsOfficial Action Indicated (OAI)3008213711

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3008213711Noblesville, IN3Mar 16, 2016

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.